Reckitt Benckiser surrenders probiotics, DHA claims for infant product

By Hank Schultz contact

- Last updated on GMT

©Getty Images - Jose Luis Paleaz Inc
©Getty Images - Jose Luis Paleaz Inc

Related tags: Infant formula products, infant health, Infant formula, claims substantiation

Nestlé has scored a point against competitor Reckitt Benckiser by inducing it to drop claims for the probiotic and DHA content of one of its infant formulas.

The claims kerfuffle came about as part of a ‘Fast Track’ case​ brought before the National Advertising Division, which is part of the US-based Better Business  Bureau National Programs.

Nestlé had challenged claims made on a Mead Johnson Nutrition (an RB division) Nutramigen brand infant formula.  The formula includes DHA and the probiotic Enflora LGG.

The specific claims Nestlé challenged were:

  • Nutramigen is "the only hypoallergenic formula with no sugar (sucrose) added.”
  • Nutramigen is "the only hypoallergenic formula with probiotics to support immune system and digestive health.”
  • Nutramigen is "the only hypoallergenic brand with expert recommended DHA amount.”

RB decided for “business purposes” ​to immediately drop the claims.  ​The NAD ruling that RB’s decision overlapped the start of the case, so it will remain open while it reviews RB’s compliance.  NAD noted that the ‘fast track’ approach was warranted in this case as it was unlikely to have to spend time reviewing complex science to determine whether these particular claims were supported by market evidence.

Nestlé has its own claims issues

Nestlé has had its own issues with the claims surrounding its infant formulas. In late June the European Food Safety Authority (EFSA) ruled that there was insufficient evidence​ to support the company’s claim that a peptide blend in its product lessened the risk of children developing atopic dermatitis.

The EFSA panel noted that Nestlé had been relying heavily on animal studies of the effect.  The one randomized, placebo controlled human study done on the effect had methodological problems that threw its conclusions into doubt, the panel ruled.

The Swiss food giant has also been taken to task by watchdog organizations for claiming that its infant formulas are “being close to breast milk or inspired by breast milk,”​ which the groups alleged is against the marketing code of the World Health Organization​.

Despite those allegations, which were raised in a 2019 report by the groups Changing Markets Foundation and SumOfUs, Nestlé still advertises some of its Gerber infant formulas as being “our closest to breastmilk.”

Related news

Related products

show more

Whitepaper: Optimizing immunity with vitamin D

Whitepaper: Optimizing immunity with vitamin D

DSM Nutritional Products | 16-Jun-2022 | Technical / White Paper

With vitamin D science evolving rapidly since the COVID-19 pandemic, our new whitepaper breaks down the latest research on the role of vitamin D in supporting...

Innovative colic solutions

Innovative colic solutions

Recorded the 07-Jul-2022 | Webinar

Colic is one of the most frequent reasons for visits to the pediatrician and can often lead to parental and infant exhaustion. As a functional gastrointestinal...

Register for free

Happier with indication-specific probiotics

Happier with indication-specific probiotics

Winclove Probiotics | 07-Jun-2022 | Product Brochure

From the very founding of Winclove Probiotics, our aim to help people, society, and the world has been an essential part of our business DNA.

Related suppliers

Follow us

Products

View more

Webinars